Target intelligence / Profile preview

Quinol-fumarate reductase (QFR)

Target
QFR
Molecular classification
Enzyme, Oxidoreductase, Complex II enzyme (respiratory chain), Integral membrane protein
01

Overview

Quinol-fumarate reductase (QFR) in Escherichia coli is a four-subunit integral membrane enzyme complex responsible for catalyzing the final step of anaerobic respiration by reducing fumarate to succinate, using reduced quinones (primarily menaquinol) as electron donors. It is functionally distinct from the homologous succinate dehydrogenase (aerobic, Complex II), with QFR preferentially operating under anaerobic conditions to enable E. coli growth when fumarate is the terminal electron acceptor. QFR's structure includes flavoprotein, iron-sulfur protein, and membrane-spanning subunits with multiple redox-active cofactors, facilitating electron transfer from the membrane-bound quinol through iron-sulfur clusters to FAD, and finally to fumarate. Inhibitors that block the quinol-binding site (e.g., HQNO) have been structurally characterized, demonstrating druggability of this bacterial respiratory target. QFR is essential for E. coli's energy metabolism in low-oxygen environments and provides a model for respiratory adaptation in anaerobes.

Other names
Fumarate reductase (quinol)Menaquinol:fumarate oxidoreductaseFrdABCD (gene complex)
02

Mechanism of action

Competitive inhibition of quinol binding site, blocking electron transfer and fumarate reduction

03

Biological functions

Anaerobic respirationElectron transportEnergy metabolismCatalysis of fumarate to succinate reduction
04

Disease associations

Infection (role in bacterial survival; relevance in infectious disease due to importance in E. coli anaerobic growth)
05

Safety considerations

Target selectivity (shared structural homology with other Complex II enzymes might present selectivity/tissue effect challenges)Essentiality for bacterial (but not mammalian) survival is generally beneficial for targeting
06

Interacting drugs

2-heptyl-4-hydroxyquinoline-N-oxide (HQNO) (inhibitor)

1 more in the full profile.

Beyond the preview

Go deeper on Quinol-fumarate reductase (QFR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quinol-fumarate reductase (QFR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call